Testosterone Drug Lawsuit Filings Rise To Over 280 Complaints Reports Wright & Schulte LLC

Share Article

Testosterone Drug Lawsuit Filings Allege Products Prescribed To Treat Low Testosterone Levels In Men Cause Heart Attacks, Blood Clots and Strokes

Testosterone Drug Lawsuit Filings Continue To Rise

Testosterone Drug Lawsuit Filings Continue To Rise

If you believe you have experienced cardiac events or other side-effects due to low testosterone treatment drugs contact the attorneys at Wright & Schulte LLC for a free legal evaluation by calling 1-800-399-0795 or visit www.yourlegalhelp.com

As pretrial proceedings continue to move forward for testosterone litigation filed in the U.S. District Court, Northern District of Illinois, Wright & Schulte LLC reports that the number of testosterone drug lawsuits filings alleging heart attacks, blood clots, and strokes are increasing due to using testosterone products such as AndroGel, Axiron and Fortesta. According to the master case list of the U.S. Judicial Panel on Multidistrict Litigation (JPML), 282 testosterone lawsuits are pending in the litigation as of January 15. The lawsuits are filed on behalf of men who allegedly suffered cardiovascular complications and death due to using products such as Androderm and Depo-Testosterone. The testosterone replacement complaints contend testosterone manufacturers failed to warn doctors and their patients about the risks associated with their products. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)[jpml.uscourts.gov/sites/jpml/files/
15-2015.pdf, January 15, 2015]

The firm continues to speak with men who believe they have suffered heart attacks, strokes or other cardiac events caused by AndroGel, Androderm, Testin and other low testosterone treatment drugs. To speak with one of our attorneys and to receive a free legal evaluation, you can contact Wright & Schulte LLC by calling 1-800-399-0795 or visit http://www.yourlegalhelp.com.

Wright & Schulte LLC notes that Low testosterone lawsuit filings have been on the rise since the U.S. Food and Drug Administration (FDA) announced in January 2014 that it was reassessing the safety and effectiveness of all FDA-approved low testosterone therapy products, that includes:

  • AndroGel
  • Androderm
  • Axiron
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Testim

Low testosterone products are used to treat men with hypogonadism, a condition in which men have low testosterone levels due to an underlying medical condition. The FDA said it was launching its probe after reviewing two observational studies that focused on the cardiovascular risks associated with testosterone use in older men. One study, published in the November 2013 Journal of the American Medical Association, found that older men with an underlying cardiovascular disease who took testosterone products had a 30 percent increased risk of having a stroke, heart attack or death compared to men who did not take testosterone replacement therapy. The second study, published in the PLOS One Journal on January 29, 2014, found that men over 65 and younger men with a pre-existing heart disease were at a greater risk of having a heart attack within the 90 days after taking low testosterone drugs for the first time.
[http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]
[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805, January 29, 2014]
[http://jama.jamanetwork.com/article.aspx?articleid=1764051, November 6, 2013]

Most of the testosterone drug lawsuits filed under MDL 2545 are consistent with men suffering heart attacks and strokes such as a man from Louisiana who alleges he suffered a heart attack after taking Depo-Testosterone medication (Case No. 1:14-cv-10197) and a man from Maryland who suffered a stroke and a heart attack allegedly after using Testim. (1:15-cv-00494).

Wright & Schulte LLC has found that while federally filed testosterone drug lawsuits are centralized in the Northern Illinois federal court, and that testosterone cases are also being filed in state courts, including California, Indiana, Missouri and Pennsylvania. U.S. District Judge Matthew Kennelly, who is managing the federal testosterone replacement therapy litigation, appointed four plaintiffs' attorneys to serve as liaisons between the federal court and state courts. Judge Kennelly issued a Case Management Order (CMO) on January 7 stating his goal to coordinate parallel and overlapping pretrial proceedings in the state and federal testosterone complaints as a way to reduce costs and avoid unnecessary duplication of efforts. In his CMO, Judge Kennelly assigned the attorneys the task of keeping in regular contact with plaintiffs' attorneys in the state court cases as well as providing the latest developments in the federal testosterone litigation to the attorneys in state courts. (In re: Testosterone Replacement Therapy Product Therapy Litigation – MDL No. 2545)

Wright & Schulte LLC, an experienced personal injury product liability firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free testosterone lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
Like us on Facebook
Follow us on Twitter
Join us on Google+

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Richard Schulte

Corey Artim
Follow us on
Visit website